Rational Pharmacotherapy in Cardiology

Advanced search


Online Submissions

Already have a Username/Password for Rational Pharmacotherapy in Cardiology?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

Start submission

Author Guidelines

The “Rational Pharmacotherapy in Cardiology” Journal Requirements for Submission and Publication

The following Requirements for publication in the «Rational Pharmacotherapy in Cardiology» (RPC) Journal were developed according to the uniform requirements, stated by the International Committee of Medical Journal Editors (ICMJE) in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication” located on the site The Requirements regulate relations between the Editors of the RPC Journal further called "the Editors", and an author who submits an article for publication, further called "the Author".

The (RPC) Journal publishes reviewed articles that cover all aspects of cardiovascular diseases, including original clinical researches, experimental researches with the clinical importance, reviews on current problems in cardiology, and also clinical case studies. Usually 6 issues are published annually (or one issue every 2 months); the number of issues can be increased to 8 issues annually.

1. Submission requirements/publishing policy

1.1. An article should be submitted to the following e-mail address:

Editorial office tel: +7 (499) 553-68-10.

1.2. The manuscript is accepted for further consideration only if it has not been submitted to any other journals, published in the Internet or published previously.

1.3. The Author, submitting the manuscript to the Editor, assigns the Editor to publish it. The Editors have the right to provide the manuscript with any illustrated or text material, including advertisements. The Editors allow the third parties to put such content into the manuscript.

1.4. Submission of the manuscript to the Editors implies that the Author agrees to transfer the exclusive property rights for the manuscript and other objects of the copyright, like photos, drawings, schemes, tables, etc. to the Editors. The Editors obtain the right to reproduce (partly or fully) all the content submitted, including objects of the copyright, in press and on Internet; to distribute; to translate the manuscript and other provided content into any language of the world; to export and import copies of the issue where the article of the Author was published; to revise the manuscript.

1.5. The Author transfers the rights specified in clauses 1.3 and 1.4 to the Editors without any time limitations or territory restrictions, including the territories of the Russian Federation.

1.6. The Editors have the right to transfer the rights received from the author to the third party or to prohibit any use of materials published in the journal by the third party.

1.7. The Author guarantees that he or she holds the copyright to all materials submitted to the RPC Journal. In case of violation of this guarantee by the Author and consequent claims to the Editors, the Author is obliged to settle all the claims at his/her own expense. The Editors are not responsible for copyright violation by the Author.

1.8. The Author retains the right to use the published material or its parts for personal needs, including scientific and educational purposes. The Author retains the right to publish the parts of the article in other editions with obligatory reference to the main article, published in the RPC Journal.

1.9. The copyright is considered transferred to the Editors since the issue with the article passes for printing.

1.10. Reprinting of the article published in the RPC Journal by the third parties is only possible provided the written permission of the Editors. Reference to the issue of the RPC Journal in which the article was published and to the year of publication is obligatory.

1.11. The Editors are obliged to provide the Author with one copy of the issue where the article is published. The Author(s) should provide his/her (their) full mail address(es) including index(es) at the end of the manuscript.

1.12. Manuscripts can be reviewed by independent experts. All manuscripts are reviewed on the double blind reviewing basis - neither the Authors know who reviewers are, nor the reviewers know who the Author of each particular manuscript is. The name of institution, where the Author works or makes research remains confidential as well. Reviewers’ comments and opinions can be sent to the Author for making changes or corrections. In case of untimely answer of the Author the Editors have the right to make their own independent scientific editing and to make corrections to the publication or to refuse to publish the article. Editing, shortening and correction of the manuscript, and changes in the graph, picture or table design are made in order they comply the standards of the RPC Journal. The meaning of the submitted content should not be changed after corrections.

1.13. The Editors are not responsible for reliability of the information presented in the manuscripts.

1.14. The Editors recommend[1] that submitted manuscripts conform the uniform requirements, stated by the International Committee of Medical Journal Editors (ICMJE) in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication” published in №1-2 of 2010, available on the RPC Journal website , in the “For Authors” section.

1.15. Articles submitted with violation of requirements for design and formatting will not be accepted by the Editors.

2. General recommendations for submission of original scientific works

2.1. The Editors recommend* that results of randomized controlled trials conform the “Consolidated Standards of Reporting Trials (CONSORT)” developed by scientists and editors, and published in the RPC Journal №4-6, 2010 and №1, 2011. The information is also available on the RPC Journal website in the “For Authors” section.

2.2. An article should be typed using the Times New Roman font (12 points, double interval, and2 cmtop, bottom, right and left margins). The volume of an article with the list of references, schedules, drawings and tables should not exceed 12 standard typewritten pages (1 page is 1800 symbols, including spaces); a case study should not exceed 6 standard pages; reviews and lectures should not exceed 25 standard pages.

2.3. Manuscripts should be organized as follows: 1) title page; 2) structured summary and keywords; 3) list of abbreviations; 4) text; 5) acknowledgements (if applicable); 6) list of references; 7) names and legends of pictures, tables, schemes, and photocopies in order they appear in the manuscript; 8) drawings, tables, schemes, and photocopies should be submitted on separate pages in order they appear in the manuscript. Numeration of pages should begin from the title page.

2.4. If pictures, tables, schemes, or photocopies used in the article have been published earlier, references to the authors and publication sources are necessary. It is preferable that the Author has official permission* to use such objects. The Editors recommend that figures in tables are not repeated, but only described in the text.

2.5. Manuscripts based on reviews of original research works should contain the following sections: Introduction (reflecting an urgency of a problem and research goals); Material and methods; Results; Discussion of the obtained results and Conclusion. The text should be clear, brief and without repeating.

3. Publication of uncontrolled trials results

3.1. An uncontrolled trial is a research without control group.

3.2. Articles based on uncontrolled trials results will be accepted for publication in the «Practical experience» column only if the uncontrolled design of the study is mentioned in “Material and methods” and “Discussion” sections. It is important not to exaggerate significance of the obtained results in the “Conclusion” section.

4. Ethical aspects

4.1. Trials should be held in accordance with the main principles of "Good Clinical Practice”. Participants of a trial should be informed about the purposes and main aims. They must sign their written informed consent to participate in the trial. The «Material and methods» section must contain details of the above-stated procedure, and notification that Ethical committee has approved the trial report. If a trial includes radiological methods it is desirable* to describe these methods and exposition doses in the «Material and methods» section.

4.2. Patients have the right to privacy and confidentiality of their personal data. Therefore, information containing pictures, names, and initials of patients or numbers of medical documents should not be presented in the materials. If such information is needed for scientific purposes, it is necessary to get written informed consent of the patient (or the parent, the trustee, close relatives when it is applicable) for its publication in print or electronically. If necessary, written consent should be presented to the Editors at request.

4.3. Animal trials must conform to the International Guiding Principles for Biomedical Research Involving Animals, adopted by the Council for International Organizations Of Medical Sciences (CIOMS) in 1985.

5. Authorship

5.1. Each author should significantly contribute to the work submitted for publication.

5.2. If more than 4 authors are indicated in the author's list, it is desirable* to describe contribution of each author in the covering letter. If the authorship is attributed to a group of authors, all members of the group must meet all criteria for authorship. For economy of space members of the group can be listed in a separate column at the end of the article. Authors can participate in the submitted manuscript in the following ways: 1) working out the concept and design or analysing and interpreting of data; 2) substantiating the manuscript or checking the crucial intellectual content; 3) giving final approval of the manuscript. Participation in data gathering only does not justify the authorship (such participation should be noted in the Acknowledgements section). Manuscripts should be submitted with the covering letter containing the following information: 1) the article is not submitted to any other media; 2) the article has not been published earlier; 3) all authors have read and approved of the manuscript; 4) the article contains full disclosure of any conflict of interests, 5) the author/authors are responsible for the reliability of the materials presented in the manuscript. The author responsible for the correspondence should be specified in the covering letter.

6. Conflict of interests/financing

6.1. It is necessary for authors to disclose (in a covering letter or on the title page) any possible relationships with industrial and financial organizations, which can lead to a conflict of interests with regard to the content of the article. It is also desirable to list all sources of financing in a footnote on the title page.

7. Manuscript content

7.1. Title page

7.1.1. It should include the article title in Russian and English, full given names and last names of the authors, the full name of the institution(s) from which the manuscript came, its(their) full mail address(es) with postal code. The article title should not contain trade names of drugs. The name(s) of the author(s) should also be submitted in the author’s approved English spelling. The name(s) of the institution should also be submitted in the authorized English spelling.

7.1.2. Information about authors, including the author’s scientific degrees and titles, positions at the institution from which the manuscript came. The names of units, in which the authors work (chair, department, laboratory, etc.) must be submitted in the authorized English spelling, or should be pointed out that the official spelling is absent.

7.1.3. A short title of the article (limited to 45 symbols) to be put on headlines.

7.1.4. Provide full name, full mail address, e-mail address, and phone number of the “Corresponding author” who will be responsible for any contacts with the Editors.

7.1.5. It is necessary to provide statement about conflict of interests for every authors, information about grants, contracts and other forms of financial support of the study and publication.

7.1.6. The manuscript (or the covering letter) should be signed by all authors.


7.2. Summary

7.2.1. The text of summary for the article about results of original studies (volume - at least 300 and not more than 400 words) should contain the following sections: Aim, Material and methods, Results, and Conclusion. In the summary of the review (volume - at least 200 and not more than 300 words) it is necessary to reflect its main goal, briefly characterize used sources of data and present the main conclusion/conclusions of the review. A manuscript must contain all data presented in summary. Summary of the clinical case (volume not less than 150 and not more than 200 words) should be structured and reflect the main description of the case, the reasons for presenting this particular case and the content of the overview part.

7.2.2. 5-7 keywords of the article should be given at the end of the abstract.

7.2.3. In addition to the text of summary in Russian it is necessary to submit its full translation into English.

7.3. List of abbreviations and their definitions

7.3.1. For saving space in the journal up to 10 abbreviations of general terms (for example, ECG, ICV, ACS) or names (GUSTO, SOLVD, TIMI) can be used in a manuscript. List of abbreviations and their definitions should be provided on a separate page after structured summary (for example, CABG – coronary artery bypass grafting). Special terms must be translated into Russian. Only words generally accepted in scientific literature should be used. Foreign words in ones “own” Russian transcription are strongly discouraged.

7.4. Text

7.4.1. Original studies should be structured as follows: Introduction, Material and methods, Results, Discussion and Conclusion.

7.4.2. Case studies, reviews and lectures may be unstructured, but it is desirable to include the following paragraphs: Discussion and Conclusion (Conclusions, Recommendations) into the text.

7.4.3. Please, use international names of drugs in the title. Exceptions are possible when usage of trade names is well-grounded (for example, in studies of bio- or therapeutic equivalence of drugs). It is possible to use a trade name in the text, but not more than once per standard page (1800 symbols including spaces).

7.4.4. You must provide titles and subtitles in the sections: Methods, Results and Discussion. Each reference, image or table should be numbered and specified in order of appearance in the text.

7.4.5. All units of measure should be provided in SI system. No abbreviations, except standard abbreviations of chemical and mathematical terms, are acceptable.

7.4.6. Each image, chart, table, photo, and reference must be indicated in order of appearance in the text.

7.4.7. References in the text must be numbered in Arabic figures, and provided in square brackets.

7.5. Statistics

7.5.1. All submitted materials can be revised to ensure relevance and accuracy of statistical methods and statistical interpretation of results. The Methods section should contain a subsection with detailed description of statistical methods, including those used for generalization of data; and of methods used for testing hypotheses (if those are available). Significance value for testing hypotheses must be provided. Please indicate statistical software which was used to process results and its version if you use more complex statistical methods (besides a t-test, a chi-square, simple linear regression),

7.6. Acknowledgements

7.6.1. The Acknowledgements section or Appendix should not exceed 100 words.

7.7. References

7.7.1. Please use separate sheet and double interval for the list of references. Give each source a consecutive number and start it with the new line. The list of references should be composed in order of citation. Use Index Medicus to search for abbreviations of the names of journals.

7.7.2. All documents referred to in the text, should be included into the list of references.

7.7.3. The list of references should not include any dissertations, thesis published more than two years ago, or information which is impossible to check (local conferences materials, etc.). If material was taken from thesis, please, mention that in brackets — (thesis).

7.7.4. It is desirable* to refer to periodicals approved by the State Commission for Academic Degrees and Titles.

7.7.5. In order to increase the quotation of authors, transliteration (translation of the Cyrillic script into the Latin alphabet) of Russian-language sources using official encodings is mandatory in the following order: authors and the name of the journal are transliterated using encodings, and the title of the article – a semantic translation into English. If a source has an original transliteration, the latter is used. You can use online services: (basic) for making transliteration. Below there are examples of the transliteration of Russian-language (Cyrillic) sources into the Latin alphabet.


A Russian-language source that does not have an original transliteration:


Скворцов В.В., Халилова У.А. Актуальные вопросы диагностики и лечения инфаркта миокарда. Поликлиника 2016;2(1):66-70.


Transliteration and the form of presentation of the source in the list of literature:


Skvorcov V.V., Halilova U.A.Actual questions of diagnostics and treatment of myocardial infarction. Poliklinika 2016;2(1):66-70. (In Russ.) [Скворцов В.В., Халилова У.А. Актуальные вопросы диагностики и лечения инфаркта миокарда. Поликлиника. 2016;2(1):66-70].


A Russian-language source with an original transliteration:


Смирнова М.И., Оганов Р.Г., Горбунов В.М. и др. Скрытая неэффективность лечения артериальной гипертонии: частота и предикторы. Кардиоваскулярная Терапия и Профилактика 2011;10(6):11-7].


Transliteration and the form of presentation of the source in the list of literature:


Smirnova M.I., Oganov R.G., Gorbunov V.М. The hidden ineffectiveness of treatment of arterial hypertension: frequency and predictors. Cardiovascular Therapy and Prevention 2011;10(6):11-7. (In Russ.) [Смирнова М.И., Оганов Р.Г., Горбунов В.М. и др. Скрытая неэффективность лечения артериальной гипертонии: частота и предикторы. Кардиоваскулярная Терапия и Профилактика. 2011;10(6):11-7].


7.7.6 Authors are responsible for accuracy of information provided in the list of references.

7.7.7 The list of references should conform to the format recommended by the American National Information Standards Organisation (NISO), accepted by the National Library of Medicine (NLM) for its databases (Library’s MEDLINE/Pub Med database) and updated in 2009. Authors should use the official site of NLM: to look for recommended formats for various types of references. Examples of references provided in accordance with the NLM recommendations are given below:

7.7.8. After the bibliographic reference, you must specify the digital identifier of the source hosted on the Internet – doi (digital object identifier) – if available.

For example,

Heneghan C, Ward A, Perera R. et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet. 2012;379(9813):322-34. doi: 10.1016/S0140-6736(11)61294-4.


  • Go A.S., Hylek E.M., Phillips K.A. et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285(18):2370-5.

Sources in Russian with transliteration:

Baevskiy R.M., Ivanov G.G., Chireykin L.V. et al. Analysis of heart rate variability using different ECG systems (guidelines). Vestnik aritmologii 2002; 24: 65-86. Russian (Баевский Р.М., Иванов Г.Г., Чирейкин Л.В. и соавт. Анализ вариабельности сердечного ритма при использовании различных электрокардиографических систем (методические рекомендации). Вестник аритмологии 2002; 24: 65-86)..

Please provide initials aftere last names of authors. Last names of foreign authors are given in the original transcription. Names of periodicals can be abbreviated. Usually such abbreviations are accepted by the Editors of those periodicals; you can find them on the Publisher’s site or in the list of abbreviations of Index Medicus.

Punctuation in the list of references should be considered. Comma should not be put between the name of the journal and the year of its release, after the year of release a semicolon is put without a space, then a colon follows the volume number, and finally page numbers are given. There are no indications like ”volume”, ”№”, "pages". Russian periodicals often have no indication of volume or through numbering of pages within a year. In this case a number of issue should be specified in brackets.

If total number of authors exceeds four people, please provide the names of first three authors and put “et al.” afterwards. If there are not more than 4 authors, full list of authors is provided.

Chapters in a book

  • Swanton R.H., Banerjee S. Cardiac Failure. In: Swanton R.H., Banerjee S., eds. Swanton’s Cardiology: A concise guide to clinical practice Sixth Edition. Oxford: Blackwell Publishing; 2008. pp. 255-309.

Sources in Russian with transliteration:

  • Belenkov Yu.N. Cardiomyopathies. In.: Chazov E.I., Belenkov Yu.N., eds. Rationale for drug therapy of cardiovascular diseases: A guide for medical practitioners. Moscow: Litterra Publishers; 2006. pp. 431-452. Russian (Беленков Ю.Н. Кардиомиопатии. В кн.: Чазов Е.И., Беленков Ю.Н., редакторы. Рациональная фармакотерапия сердечно-сосудистых заболеваний: Руководство для практикующих врачей. М.: Литтерра; 2006. с. 431-452).

Reference to a book chapter should be arranged in the following order: authors of the corresponding chapter; name of the chapter; «In:»; editors (title authors) of the book; name of the book;, number of issue, publisher; city of publishing; year of publishing; pages of the corresponding chapter. Punctuation should be considered. There are no quotation marks. You can use abbreviations M and SPb for Moscow and St.-Petersburg respectively in Russian sources.


Sources in Russian with transliteration:

  • Shlyakhto E.V., Konradi A.O., Tsyrlin V.A. The autonomic nervous system and hypertension. SPb.: Meditsinskoe izdatel'stvo; 2008. Russian (Шляхто Е.В., Конради А.О., Цырлин В.А. Вегетативная нервная система и артериальная гипертензия. СПб.: Медицинское издательство; 2008).

Websites should be provided in the list of references, but not in the text. References to websites should be made only when original text is not available. References should be provided in the following way:

WHO. Severe Acute Respiratory Syndrome (SARS). Last update: June 1 2010. Last access: June 10 2010.

7.8. Diagrams, charts, and drawings

7.8.1. Diagrams, charts, and drawings should be submitted electronically in the following formats: «MS Excel», «Adobe Illustrator», «Corel Draw» or «MS PowerPoint». Diagrams, charts, and drawings must be allocated on separate pages, numbered in order of citation, have names and notes if necessary. They must not repeat content of tables. Please indicate names and units of measurement for graph axes. Provide legend for each graph (denote lines and filling). If you compare diagrams, provide significance of differences. Do not use 3-D models for histograms. Please identify places in the text, where you wish schemes, drawings and graphs to be inserted.

7.8.2. Photographs must be submitted electronically with a minimum resolution of 300 dots per inch (dpi). Microphotos must be cropped so that only main content is left. Arrows should be used to show main features. All symbols, arrows and legends on gray-scale illustrations should be in contrast with the background.

7.8.3. Size of legends on images and photos should be big enough to be legible after compression for publication. The optimal size is 12 points.

7.8.4. All abbreviations should be defined either after first citation in a legend, or in alphabetic order at the end of each legend. All symbols (arrows, circles, etc.) must be explained.

7.8.5. If data was published earlier, it is desirable* to provide a written permission from the publisher.

7.9. Tables

7.9.1. Tables should be typed with double interval, have numbers in order of citation in the text, and names. Tables should be compact and demonstrative. Names of columns and rows must reflect the content. Data presented in tables, should not be repeated in the text or images. Please clearly specify units of measurement of variables and form of data presentation (M±m; M±SD; Me; Mo; percentiles etc.). All figures, sums and percentages must be thoroughly checked and correspond to those in the text.. Explanatory footnotes should be provided below the table if necessary.

7.9.2. Abbreviations should be listed in a footnote under the table in alphabetic order. Symbols of footnotes should be given in the following order: *, †, ‡, §, | |, ¶, #, **, † † etc.

7.9.3. If tables were published earlier, it is desirable to provide a written permission* from the publisher.

Corresponding Member of the

Russian Academy of Sciences,

Professor                                                                                                                                        Boytsov S.A.

[1]Hereinafter: fulfilment of the Editors recommendations will be contributed to faster editing, acceptance and publishing of submitted manuscript 


The form for the potential conflicts of interest disclosure


Copyright Notice

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).


Data Privacy Statement

Specified when registering the names and addresses will be used solely for technical purposes of a contact with the Author or reviewers (editors) when preparing the article for publication. Private data will not be shared with other individuals and organizations.